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7. A statement of conflicts of interest for the authors; and
8. Sources of financial and other support for developing 
the guideline.
The searches may have missed relevant information. The 
authors report their searches covered a period from 1968 to 
2011, identifying over 2,000 citations. When we made a 
PubMed search until the end of 2011 using “central venous 
catheter” as the search term, we found 12,453 references; 
adding “infection” retained 4,729 of these; and adding 
“coated” resulted in 128 studies, including a cohort study 
of catheters coated with antibiotics published in 2011.4 This 
study shows such catheters significantly decreased infections 
“in a manner that was independent and complementary 
to the infection control precautions.” In the paragraph on 
Recommendations for Use of Catheters Containing Anti-
microbial Agents, the guideline has no references. A clear 
description of the search strategies could explain such a 
discrepancy.
The concept of “evidence linkage” is rather central for the 
methodology but not quite fully explained in the methods. Does 
it mean “a statement regarding potential relationships between 
clinical interventions and outcomes” (as in appendix 5)?
In reporting the results, we would appreciate separating 
the recommendations based on published scientific evi-
dence and opinion-based evidence. Reading the guideline, 
it was first unclear to us whether the letters (e.g., Category 
B2 evidence) referred to scientific evidence or opinion-based 
evidence. Getting to the footnote of appendix 5, it seems 
the categories refer to scientific evidence only. It would be 
interesting to learn whether the guideline group for the next 
 version could consider using a more widely used grading 
system, such as the GRADE (The Grading of Recommenda-
tions Assessment, Development and Evaluation).5
It may be that we have missed where the authors have 
referred to the methods used, although we did our best to 
study the publication and the Supplemental Digital Con-
tent carefully. We also searched the website of this Journal†  
to make sure we did not miss any information on guideline 
methodology. In many guidelines, for example in a recent 
one on the prevention of intravascular catheter-related infec-
tions,6 the methodology is provided on an external site.‡
Finally, we would have appreciated seeing the conflict of 
interest statements for all authors, and a declaration of how 
this undoubtedly work-intensive process has been funded.
Making the evidence more transparent would be help-
ful to guideline users. Our suggestions are anchored in prin-
ciples of evidence-based medicine. Our aim with this letter 
is to encourage the authors to provide information which 
could increase our confidence in the guideline and thus pro-
mote its application in practice.
We hope that this important guideline will be updated 
within a couple of years, and that the American Society of 
Anesthesiologists Task Force on Central Venous Access will 
consider adding the necessary methodological information 
in their guideline.
Transparent Guideline Methodology 
Needed
To the Editor:
As part of learning at the Nordic Workshop of Evidence-
based Medicine, we have read with interest the practice 
guidelines for central venous access, published in your 
Journal in 2012.1 We appraised the quality of this guide-
line using the checklist developed by The Evidence-Based 
Medicine Working Group.2 Similar criteria for guideline 
quality have been suggested elsewhere.3 Our conclusion was 
that this much needed guideline is currently unclear about 
several aspects of the methodology used in developing the 
recommendations. This means potential users cannot be cer-
tain that the recommendations are based on best currently 
available evidence.
Our concerns are in two main categories: the rigor of 
development, including methodology of searching, evalu-
ating, and combining the evidence; and editorial indepen-
dence, including funding and possible conflicts of interest. 
The methodological issues that we would like to see clarified 
in the guideline are:
1. Searches for literature: details of search strategies and 
databases used, including the search terms and strategies 
used in different databases;
2. Criteria for selecting the evidence: inclusion and 
exclusion criteria for publications found through the 
searches;
3. Process of selecting the evidence: number of persons 
independently applying the criteria at each step of selec-
tion and ways of solving disagreement;
4. Process and criteria of appraising the quality of studies 
for inclusion;
5. Methods used for synthesizing the evidence;
6. Results of meta-analyses (including tests for 
heterogeneity);
† Available at: www.anesthesiology.org. Accessed May 29, 2013.
‡ Available at: www.cdc.gov/hicpac/guidelineMethod/guideline-
Method.html. Accessed May 29, 2013.
Funding was provided by the Norwegian Knowledge Centre 
for Health Services (NOKC), Oslo, Norway; Vestfold Hospital Trust 
(Tonsberg, Norway); and National Institute for Health and Welfare 
(THL), Helsinki, Finland. 
clinical trial of mechanical bowel preparation in elective 
colonic resection. Br J Surg 2007; 94:689–95
 5. Seiler CM, Deckert A, Diener MK, Knaebel HP, Weigand MA, 
Victor N, Büchler MW: Midline versus transverse incision in 
major abdominal surgery: A randomized, double-blind equiv-
alence trial (PoVAti: iSRCtN60734227). Ann Surg 2009; 
249:913–20
(Accepted for publication June 11, 2013.)
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In Reply:
We thank Dr. Lidal, Ms. Norén, and Dr. Mäkelä for their 
comments on the Practice Guidelines for Central Venous 
Access.1 We were quite surprised at a request for more 
transparency, as the American Society of Anesthesiologists 
evidence-based process for guideline development is remark-
ably transparent compared with other published guidelines. 
Nonetheless, we are delighted to have the opportunity to 
describe our process.
Regarding our literature search, we agree that informa-
tion pertaining to search terms and databases used was not 
specified in the guidelines, although an outline of the general 
search strategy used in the development of all of our guide-
lines is readily available.2–4 We typically begin with PubMed 
and expand our search where appropriate (e.g., Cochrane 
Systematic Review Database, Cochrane Database of Clini-
cal Trials). The search is supplemented by hand searches of 
reviewed studies and additional citations provided by the task 
force, consultants, and others. Searches are typically limited 
to studies reporting original data published in peer-reviewed, 
English-language journals. Editorials, letters (unless a relevant 
case is described), and the reporting of meta-analyses con-
ducted by others are excluded. Inclusion and exclusion criteria 
for literature can be found in the “Focus” section of the guide-
lines (pages 539–540). By applying these exclusionary criteria, 
the search protocol easily reduces to the smaller number of 
appropriate citations indicated in appendix 5 (page 553). Our 
two methodologists applied these selection criteria, as part of 
the search and review process. Articles selected were, in turn, 
verified by means of a reliability assessment involving the 
entire 12-member task force. Findings from this assessment 
are described in appendix 5 (page 554).
The process and criteria for appraising the quality of stud-
ies for inclusion and methods used for synthesizing evidence 
are described under the heading “scientific evidence,” pages 
540–541, and in appendix 5 (pages 553–554). Meta-ana-
lytic results, including tests for heterogeneity, are reported in 
appendix 5 (page 554), table 1 (page 555), and throughout 
the text in the guidelines.
A statement regarding conflict of interest was not 
included in the guidelines, although participation in the 
task force includes completion of a standard conflict of 
interest form. Those with major conflicts of interest are 
excluded from the task force. Financial support was pro-
vided entirely by the American Society of Anesthesiologists. 
All physician members of the task force were volunteers, 
who in total contributed hundreds of work hours in devel-
oping the guidelines.
The literature search was very thorough and was guided 
by the evidence linkage interventions described in appendix 
5 (pages 553–554) and the inclusion/exclusion criteria in the 
“Focus” section. In the document, we specifically reported the 
highest level of evidence, as described on pages 540–541. All of 
the literature reviewed for these guidelines is available as supple-
mental digital content from the journal’s website. The reporting 
format for all of the American Society of Anesthesiologists prac-
tice parameters first reports literature-based evidence, followed 
by opinion-based evidence, and then the recommendations. 
Evidence, including meta-analytic findings pertinent to the use 
of catheters containing antimicrobial agents, can be found on 
pages 542–543. Of further note, the article by Ramos et al.5 
cited in your letter, while published subsequent to formulation 
of the guidelines, would not have been included in our eviden-
tiary database because it addressed long-term use of catheters.
As noted in our “Scientific Evidence” section, we rely first 
on the best scientific evidence available and use opinion-
based surveys and other resources to provide guidance for 
practicality and feasibility purposes. For these guidelines, 
we conducted formal surveys of 55 expert consultants and 
251 practicing physicians to determine appropriateness and 
practicality of our recommendations, as well as used addi-
tional surveys and informal opinion to assess the validity and 
feasibility of implementing the guidelines. When scientific 
evidence is unavailable, opinion-based evidence from experts 
and from our general membership becomes the only formal 
resource available to provide guidance to the task force.
Ingeborg Lidal, M.D., Ph.D., Camilla Norén, R.N., 
 Marjukka Mäkelä, M.D., Ph.D., M.Sc.(ClinEpi).* *Finohta 
(Finnish Office for Health Technology Assessment) at THL 
(National Institute for Health and Welfare), Helsinki, Fin-
land. marjukka.makela@thl.fi 
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